Potential approaches using teneligliptin for the treatment of type 2 diabetes mellitus: current status and future prospects-Reference-Cited by-同舟云学术

Potential approaches using teneligliptin for the treatment of type 2 diabetes mellitus: current status and future prospects

Published:2023-01-02 Issue:1 Volume:16 Page:49-59
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Singh Harmanjit¹^ORCID,Singh Jasbir²,Bhangu Ravneet Kaur³,Singla Mandeep⁴,Singh Jagjit¹,Javid Farideh⁵

Affiliation:

1. Department of Pharmacology, Government Medical College & Hospital, Chandigarh, India

2. Department of Pharmacology, Government Medical College & Rajindra Hospital, Patiala, India

3. Department of General Medicine, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK

4. Department of Medicine, Government Medical College & Hospital, Chandigarh, India

5. Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, UK

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2163386

Reference73 articles.

1. Centers for Disease Control and Prevention. Type 2 Diabetes cited 2022 Jan 8]. Available from 2022 Jan 8: https://www.cdc.gov/diabetes/basics/type2.html.

2. Worldpopulationreview.com. Diabetes Rates by Country cited 2022 Jan 8]. Available from 2022 Jan 8: https://worldpopulationreview.com/country-rankings/diabetes-rates-by-country.

3. Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends

4. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022

5. Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability-indicating green HPLC method for fixed-dose tablets containing remogliflozin etabonate and teneligliptin: an AQbD approach;Drug Development and Industrial Pharmacy;2024-09-11

2. Efficacy and safety of teneligliptin in patients with type 2 diabetes mellitus: a Bayesian network meta-analysis;Frontiers in Endocrinology;2023-12-18

3. Comparison of teneligliptin and other gliptin-based regimens in addressing insulin resistance and glycemic control in type 2 diabetic patients: a cross-sectional study;Expert Review of Endocrinology & Metabolism;2023-12-11

4. The MEK-ERK-Egr-1 axis and its regulation in cardiovascular disease;Vascular Pharmacology;2023-12